＜書籍＞
著者氏名

論文タイトル名

書籍全体
の編集者名

安藤裕実、
小嶋哲人

新規抗凝固薬（抗 Xa、抗トロ
ンビン約）のポ
テンシャル

Tomiyama Y

出版社名

出版地 出版年

ページ

編:直江知 血液疾患 最樹、小澤敬 新の治療也、中尾眞 2014-2016
二編

南江堂

東京

2014

54-58

Thrombopoietin
receptoragonists.

Salama A

Current &Emerging
Treatments
for Immune
Thrombocyto
penia.

FutureMedicineUK2013

88-106

冨山佳昭

特発性血小板減少性紫斑病．

今日の治療
山口徹,
北原光夫, 指針 2013年
福井次矢 版

医学書院

東京

2013

621-623

藤村欣吾

ループスアンチ
コアグラント（LA）

Medical
臨床検査
Practice ガイド 2013
編集員会 ～2014
（和田攻、
大久保昭
行、矢崎義
雄、大内尉
義）

文光堂

東京

2013

651-653

藤村欣吾

出血性疾患

北村

臨床病態学
1

ヌーヴェ 東京
ルヒロカ
ワ

2013

613-627

高木 明、
小嶋哲人

凝固因子

編:朝倉英 臨床に直結
策
する血栓止
血学

中外医学 東京
社

2013

67-69

小嶋哲人

凝固障害、線溶障害

編:小川聡 改訂第 8 版
中山書店
内科学書
Vol.6 血液・造血器疾患、神経疾患東京

2013

187-192

小林隆夫

II. 各論 1. 産
婦人科 A 産科

瀬尾憲正, 周術期深部
古家仁
静脈血栓/肺血栓塞栓症

克誠堂出 東京版

2013

101-119

榛沢和彦

災害医療と肺血
栓塞栓症

永井厚志
巽 浩一
郎

中外医学 東京社

2013

146-152

聖

書籍名AnnualReview 呼吸器冨山佳昭

トロンボポエチン受容体作動薬の安全性と副作
用をみる －副作用の頻度とそ
の対策－.

池田康夫

先端医学 東京
社

2012

62-74

冨山佳昭

ITP における TPO 高久史麿, ITP における 中外医学 東京
受容体作動薬の 小澤敬也, TPO 受容体作 社
使い方.
坂田洋一, 動薬の使い
金倉 譲, 方.
小島勢二

2012

198-206

藤村欣吾

ITP 治療におけるトロンボポエチン受容体作動薬に期待される役割（臨床的意義）を教えてく
ださい

池田康夫

トロンボポ
エチン受容
体作動薬の
すべて

先端医学 東京
社

2012

111

藤村欣吾

血液・造血器の
疾患

日本薬学
会編

スタンダー
東京化学 東京ド薬学シリ同人ーズ 6 薬と疾病 II.
薬物治療（1）
第2版

2012

93126

藤村欣吾

多発性骨髄腫

放射線被
爆者医療
国際協力
推進協議
会

原爆放射線
の人体影響

文光堂

東京

2012

170
179

藤村欣吾

特発性血小板減 正岡徹
少性紫斑病（2）
成人

静注用免疫
グロブリン
製剤ハンド
ブック

メディカ 大阪
ルレビュ
ー社

2012

79-90

藤村欣吾

特発性血小板減少性紫斑病（Ｉ
ＴＰ）治療におけるトロンボポ
エチン受容体作動薬の位置付け
を探る

トロンボポ
エチン受容
体作動薬の
すべて

先端医学 東京
社

2012

76－86

池田康夫

トロンボポ
エチン受容
体作動薬の
すべて

－

川﨑富夫

未熟児網膜症姫路日赤事件最高裁判決と医療現
場感覚との落差―司法と医療の認識統合を求め
て

甲斐克則

医事法講座
信山社
第 3 巻 医療
事故と医事
法

東京

2012

3-27

川﨑富夫

肝硬変の治療にあたり、生体肝移植について説明すべき義務の違反があるとさ
れた事例

日本医事
法学会

年報医事法
学

日本評論 東京社

2012143-148

川﨑富夫

混合診療

日本医事
法学会

年報医事法
学

日本評論 東京社

2012208-213

榛沢和彦

災害時に起こりやすい循環器疾患—肺血栓塞栓症・深部静脈血
栓症

心臓病学
会

循環器内科
医のための
災害時医療
ハンドブッ
ク

日本医事 東京新報社

2012

88-93.

涌井昌俊、
村田 満

線溶系分子マーカー（フィブリン/フィブリノ
ゲン分解産物（FDP）、プラスミンα2 –プラ
スミンインヒビ
ター複合体（PIC））

日本臨床検査ガイド
2011～2012

文光堂

東京

2011

625-360

藤村欣吾

ループスアンチ
コアグラント（LA）

MedicalPractice
編集委員
会

臨床検査
ガイド
2011~2012

文光堂

東京

2011

637-639

杉原清香、
藤村欣吾

紫斑病

横田千津 病気と薬パ子、池田宇 ーフェクト
一、大越教 BOOK 2011
夫

南山堂

東京

2011

786-790

杉原清香、
藤村欣吾

出血傾向

横田千津 病気と薬パ子、池田宇 ーフェクト
一、大越教 BOOK 2011
夫

南山堂

東京

2011

158-159

藤村欣吾

特発性血小板減少性紫斑病②成
人

正岡

徹

静注用免疫
グロブリン
製剤ハンド
ブック

メディカ 大阪
ルレビュ
ー社

2011

79－90

藤村欣吾

止血・凝固系の異常：特発性血
小板減少性紫斑病

岡庭 豊、 year note
荒瀬康司、 ATLAS 4th
三角和雄 edition

MEDICMED
IA

東京

2011

32

鈴木伸明、
小嶋哲人

先天性血栓性素因小松則夫/ 専門医のた
中外医学 東京
片山直之/ めの薬物療社
冨山佳昭 法 Q＆A：血液2011379-387

小嶋哲人

先天性凝固阻止
因子欠乏症（antithrombin, protein C,
protein S 欠損
症）

日本血栓
止血学会
編集

わかりやす
い血栓と止
血の臨床

南江堂

東京

2011

107-109

中山享之、
小嶋哲人

ワルファリンの薬効評価 V 抗血栓療法の薬効
評価は？

後藤信哉
編

-そこが知りたい 抗血栓療法-

メジカル 東京ビュー社

2011122-128

＜雑誌＞
著者名

論文タイトル名

発表誌名

巻号

ページ

出版年

Murata M, Takagi A,
Suzuki A, Okuyama E,
Takagi Y, Ando Y, Kato I,
Nakamura Y, Murate T,
Matsushita T, Saito H,
Kojima T

Development of a newlaboratory test toevaluate antithrombin
resistance in plasma.

Thromb Res

133
(2)

293-298

2014

Nakamura M, Miyata T,
Ozeki Y, Takayama M,
Komori K, Yamada N,
Origasa H, Satokawa H,
Maeda H, Tanabe N, Unno
N, Shibuya T, Tanemoto K,
Kondo K, Kojima T

Current venous
thromboembolism
management and its
outcomes in Japan: thenationwide JAVA
observational study.

Circ Jin press 2014

Sakata A. Ohmori T.
Nishimura S. Suzuki H.
Madoiwa S. Mimuro J.
Kario, K. Sakata Y.

Paxillin is an
intrinsic negative
regulator of plateletactivation in mice.

Thromb J

Epub
2014
ahead ofprint

Koyama K. Madoiwa S.
Nunomiya S. Koinuma T.,
Wada, M. Sakata, A.
Ohmori T. Mimuro J.
Sakata Y.

Combination ofthrombin-antithrombin
complex, plasminogenactivator inhibitor-1,
and protein C activity
for early
identification ofsevere coagulopathy ininitial phase of
sepsis: a prospective
observational study.

Criti care

Epub
2014
ahead of
print

高蓋寿朗

特発性血小板減少性紫斑病 –病態と診断のすすめかた-MedicalPractice

31

53-57

2014

Asano J. Ueda R. Tanaka Y. Effects ofInternal
Shinzato I. Takafuta T. Immunosuppressive
Med
Therapy in a Patientwith Aplastic
Anemia-Paroxysmal
Nocturnal
Hemoglobinuria(AA-PNH)
Syndrome during Ongoing
Eculizumab Treatment.

53

125-128

2014

Helicobacter
pylori-associatedimmunethrombocytopenia:
clinical features andpathogenic mechanisms

World J.
Gastroente
rol.

20(3)

714-7232014

Kuwana M, Okazaki Y, and Detection of
circulating B cells
Ikeda Yproducing anti-GPIb
autoantibodies inpatients with immune
thrombocytopenia

PLoS One.

9(1)e86943

2014

Hirokazu Tanaka, Chiaki
Tenkumo, Nobuhiro Mori,
Koichi Kokame, Yoshihiro
Fujimura, Toshiyuki Hata

Case of maternal andfetal deaths due tosevere congenital
thrombotic
thrombocytopenic
purpura(Upshaw-Schulman
syndrome) during
pregnancy

J Obstet
GynaecolRes

40 (1)

247-2492014

藤村吉博,松本雅則,石西綾美,八木秀男,小亀浩市,
宮田敏行

血栓性血小板減少性紫斑病

臨床血液55 (1)

93-1042014

小亀浩市,樋口由佳

Upshaw-Schulman症候群のADAMTS13遺伝子解析

細胞

46 (2)

61-63

2014

Kashiwakura Y. Ohmori T.
Mimuro J. Madoiwa S.
Inoue, M. Hasegawa M.
Ozawa K, Sakata Y.

Production offunctional coagulation
factor VIII from iPSCs
using a lentiviral
vector.

Haemophilia20e40-e442014

Platelets.
Yamaguchi Y, Abe T, Sato Effects of VerifyNow
Y, Matsubara Y, Moriki T, P2Y12 test and CYP2C19*2
testing on clinical
Murata M
outcomes of patientswith cardiovasculardisease: A systematic
review andmeta-analysis.

24(5)352-612013

Matsubara Y, Ono Y,
P9 Bone Marrow Stroma
PLoS One.
Suzuki H, Arai F, Suda T, Cells Differentiate
Murata M, Ikeda Y
into Megakaryocytes andPlatelets.

8(3)e581232013

Kuwana M

Yamaguchi Y, Moriki T,
Igari A, Matsubara Y,
Ohnishi T, Hosokawa K,
Murata M

Studies of a microchip Thromb Res. 32(2)flow-chamber system tocharacterize whole
blood thrombogenicity
in healthy individuals.

263-702013

Murata M

The future directions of Rinsho
clinical hematology in Ketsueki
2013 - hemostatic andthrombotic diseasesoverview.

54(2)

177-8

2013

谷田部陽子、荒井智子、片 新規多項目自動血球分析
桐尚子、清水長子、林文明、 装置ＸＮ-1000 の性能評
近藤民章、三ツ橋雄之、村 価
田満

日本検査血
液学会雑誌

第 14
巻第 1
号

34-40

2013

Kashiwagi H, Tomiyama Y. Pathophysiology andmanagement of primary
immunethrombocytopenia.

Int J
Hematol

98(1)

24-33

2013

Honda S,
Shirotani-Ikejima H,
Tadokoro S, Tomiyama Y,
Miyata T.

The Integrin-Linked
Kinase- PINCH-Parvincomplex supports
Integrin αIIbβ3
activation.

PLoS One8(12)e854982013

冨山佳昭

急性特発性血小板減少性
紫斑病．血液症候群（第 2版）II －その他の血液疾患を含めて－

別冊 日本
臨牀 新領
域別症候群
シリーズ

No.22

338-340

2013

冨山佳昭

難治性特発性血小板減少性紫斑病．血液症候群（第2 版）II －その他の血液疾患を含めて－

別冊 日本
臨牀 新領
域別症候群
シリーズ

No.22

351-3542013

冨山佳昭, 清水一亘,
柏木浩和

特発性血小板減少性紫斑病の病態と診断．

臨床血液

54(4)

343-3492013

冨山佳昭, 清水一亘,
柏木浩和

免疫性血小板減少性紫斑病の免疫病態

臨床免疫・
アレルギー
科

59(6)

649-657

2013

冨山佳昭

特発性血小板減少性紫斑病（ITP)．

検査と技術

41(12)

1114-1119

2013

柏木浩和，冨山佳昭

特発性血小板減少性紫斑病(ITP)の分子病態と新
規治療法．

血液フロン
ティア

23(3)

357-3662013

清水一亘, 柏木浩和,
冨山佳昭．

Primary ITP における抗 日本血栓止αIIbβ3 自己抗体のエピ 血学会誌
トープ解析：抗αIIbβ3
抗体はβプロペラドメイ
ン内の高度に限定された領域を認識する．

24(4)392-395

2013

藤村欣吾

H.pylori 感染症関連疾患 日本臨床と除菌治療の意義 特発性血小板減少性紫斑病
（ITP）

71

1436－
1441

2013

藤村欣吾

内科 Q. 特発性血小板 日本医事新減少性紫斑病で H.pylori 報
陰性例の除菌治療
A. H.pylori 陰性 ITP 症例に対する除菌療法について 6 つの報告を基にした系統的レビュー報告によると、血小板増加反応が認められた頻度は有意に H.pylori 陽性 ITP 症例に高い

No4634

56-57

2013

Masuda A, Yasuoka H,
Versican is upregulated Arthritis
Satoh T, Okazaki Y,
Res. Ther.
in circulating
Yamaguchi Y, and Kuwana M monocytes in patientswith systemic sclerosis
and amplifies a
CCL2-mediatedpathogenic loop

15(4)

R74

2013

Serum chemokine levels Mod.
as prognostic markers in Rheumatol.
patients with earlysystemic sclerosis: amulticentre,
prospective,
observational study23(6)1076-1084

2013

Shirai Y, Yasuoka H,
Intravenous
Takeuchi T, Satoh T, and epoprostenol treatmentof patients with
Kuwana M
connective tissue
disease and pulmonary
arterial hypertension
at a single center

Mod.
Rheumatol.

23(6)1211-1220

2013

Kaji K, Noreen F, Medsger Autoantibodies to
TA Jr, Satoh T, Hoshino K, RuvBL1 and RuvBL2: a
Hamaguchi Y, Hasegawa M, novel systemic

Arthritis
Care Res.

Hasegawa M, Asano Y, Endo
H, Fujimoto M, Goto D, Ihn
H, Inoue K, Ishikawa O,
Kawaguchi Y, Kuwana M,
Ogawa F, Takahashi H,
Tanaka S, Sato S, andTakehara K

In
press

Lucus M, Schnure A, Ogawa sclerosis-related
antibody associatedF, Sato S, Takehara K,
Fujimoto M, and Kuwana M with diffuse cutaneousand skeletal muscle
involvement
Washio M, Fujii T, Kuwana
M, Kawaguchi Y, Mimori A,
Horiuchi T, Tada Y,
Takahashi H, Mimori T,
and Japan MCTD study
group

Lifestyle and otherMod.
related factors for the Rheumatol.
development of mixed
connective tissue
disease among Japanese
females in comparison
with systemic lupus
erythematosus

In
press

Kuwana M, and Okazaki Y

Impaired in vivo
Arthritis
neovascularization
Rheum
capacity of endothelial
progenitor cells inpatients with systemicsclerosis

In
press

Shirai Y, Tamura Y,
Yasuoka H, Satoh T, andKuwana M

IgG4-related disease in Eur.
Respir. J.
pulmonary arterial
hypertension on
longterm epoprostenol
treatment (letter)

In
press

Kuwana M

Dysregulated negative
ISBT Sci.
immune regulators inSer.
immune thrombocytopenia

In
press

Hasegawa M, Asano Y, Endo
H, Fujimoto M, Goto D, Ihn
H, Inoue K, Ishikawa O,
Kawaguchi Y, Kuwana M,
Ogawa F, Takahashi H,
Tanaka S, Sato S, andTakehara K

Serum adhesion molecule PLoS One.
levels as prognostic
markers in patients withearly systemicsclerosis: amulticentre,
prospective,
observational study

In
press

Fan X, Yoshida Y, Honda S,
Matsumoto M, Sawada Y,
Hattori M, Hisanaga S,
Hiwa R, Nakamura F,
Tomomori M, Miyagawa S,
Fujimaru R, Yamada H,
Sawai T, Ikeda Y, Iwata N,
Uemura O, Matsukuma E,
Aizawa Y, Harada H, Wada
H, Ishikawa E, Ashida A,

Analysis of genetic and Mol Immunol 54(2)predisposing factors inJapanese patients withatypical hemolytic
uremic syndrome.

238-246

2013

Nangaku M, Miyata T,
Fujimura Y.
Bennett CL, Jacob S, Dunn
BL, Georgantopoulos P,
Zheng XL, Kwaan HC, McKoy
JM, Magwood JS,
Bandarenko N, Winters JL,
Raife TJ, Carey PM,
Sarode R, Kiss JE,
Danielson C, Ortel TL,
Clark WF, Ablin R, Rock G,
Matsumoto M, Fujimura Y.

Ticlopidine-associated Br JADAMTS13 activity
Haematol
deficient thrombotic
thrombocytopenic
purpura in 22 persons inJapan: A Report from theSouthern Network on
Adverse Reactions(SONAR).

Hori Y, Hayakawa M,
ADAMTS13 unbound to
Isonishi A, Soejima K,
larger von WillebrandMatsumoto M, Fujimura Y. factor multimers incryosupernatant:
Implications forselection of plasma
preparations for TTP
treatment.

161

Transfusion 53

896-898

2013

3192−
3202

2013

Fukushima H, Nishio K,
Asai H, Watanabe T, Seki
T, Matsui H, Sugimoto M,
Matsumoto M, Fujimura Y,
Okuchi K.

Ratio of von Willebrand Shock
Factor propeptide to
ADAMTS13 is associatedwith severity of sepsis.

39409-4142013

Kawano N, Yokota-Ikeda N,
Sugio Y, Yoshida S, Ono N,
Kuriyama T, Yamashita K,
Makino S, Inoue Y, Himeji
D, Kodama K, Uezono S,
Shimao Y, Matsumoto M,
Iino H, Fujimura Y.

Therapeutic modality of Intern Med
11 patients with TTP:
Experience in a single
institution in Miyazaki
during 2000–2011.

52

1883-18
91

2013

Doi T, Ohga S, Ito N,
Ishimura M, Suga N,
Nomura A, Takada H,
Matsumoto M, Fujimura Y,
Hara T．

Limited renal
prophylaxis in regular
plasmatherapy for
heritable ADAMTS13
deficiency．

Pediatric
Blood &
Cancer.

60

1557-1558

2013

Miyata T, Kokame K,
Matsumoto M, Fujimura Y

ADAMTS13 activity andgenetic mutations inJapanese subjects.

Hӓmostaseo
logie

33

131-137

2013

Mise K, Ubara Y,
Matsumoto M, Sumida K,
Hiramatsu R, Hasegawa E,
Yamanouchi M, Hayami N,

Long term follow up ofcongenital thrombotic
thrombocytopenic
purpuraBMC Nephrol 14

156

2013

Suwabe T, Hoshino J, Sawa
N, Ohashi K, Kokame K,
Miyata T, Fujimura Y,
Takaichi K.

(Upshaw-Schulman
syndrome) on
hemodialysis for 19
years.

Takahashi N, Wada H, Usui
M, Kobayashi T, Habe-Ito
N, Matsumoto T, Uemoto S,
Nobori T, Isaji S

Behavior of ADAMTS13 and Thromb
Res
Von
Willebrand factor
levels in patients
after living donor livertransplantation

131
(3)

225
229

2013

Seki Y, Wada H, Kawasugi
K, Okamoto K, Uchiyama T,
Kushimoto S, Hatada T,
Matsumoto T, Imai H;
Japanese Society ofThrombosis
Hemostasis/DIC
Subcommittee

A prospective analysis Internof disseminatedMed
intravascular
coagulation in patientswith infections.

52
(17)

1893
1898.

2013

Hasegawa M, Wada H,
Wakabayashi
H, Yoshida K, Miyamoto N,
Asanuma K, Matsumoto T,
Ohishi K, Shimokariya Y,
Yamada N, Uchida A,
Sudo AThe relationships among Clin Chim
hemostatic markers, the Acta
withdrawal of
fondaparinux due to a
reduction in hemoglobin
and deep vein thrombosis
in Japanese patients
undergoing major
orthopedic surgery

425

109
113

2013

Masanobu Morioka,
Masanori Matsumoto,
Makoto Saito, Koichi
Kokame, Toshiyuki
Miyata, Yoshihiro
Fujimura

Blood
A first bout ofTransfus
thrombotic
thrombocytopenic
purpura triggered byherpes simplex
infection in a
45-year-old nulliparous
female with
Upshaw-Schulman
syndrome

-

-

印刷中

Masashi Akiyama, Daisuke
Nakayama, Soichi Takeda,
Koichi Kokame, Junichi
Takagi, Toshiyuki Miyata

J Thromb
Crystal structure andHaemostenzymatic activity ofan ADAMTS13 mutant with
the East Asian-specific
P475S polymorphism

11 (7)

1399-1406

2013

Yoshie Takizawa, Yukiko
Kosuge, Hiroyo Awaji, Emi
Tamura, Ayako Takai,
Takaaki Yanai, Reiko
Yamamoto, Koichi Kokame,Toshiyuki Miyata, Rieko
Nakata, Hiroyasu Inoue

Up-regulation ofendothelial nitricoxide synthase (eNOS),
silent mating type
information regulation
2 homologue 1 (SIRT1)
and autophagy-related
genes by repeatedtreatments withresveratrol in humanumbilical vein
endothelial cells

Brit J Nutr 110(12)2150-2155

2013

Yusuke Satoh, Takafumi
Yokota, Takao Sudo,
Motonari Kondo, Anne Lai,Paul W. Kincade, Taku
Kouro, Ryuji Iida, Koichi
Kokame, Toshiyuki
Miyata, Yoko Habuchi,
Keiko Matsui, Hirokazu
Tanaka, Itaru Matsumura,
Kenji Oritani, Terumi
Kohwi-Shigematsu, Yuzuru
Kanakura

The Satb1 protein
directs hematopoietic
stem celldifferentiation toward
lymphoid lineages

Immunity

38 (6)

1105-1115

2013

Koki Mise, Yoshifumi
Ubara, Masanori
Matsumoto, Keiichi
Sumida, Rikako
Hiramatsu, Eiko
Hasegawa, Masayuki
Yamanouchi, Noriko
Hayami, Tatsuya Suwabe,
Junichi Hoshino, Naoki
Sawa, Kenichi Ohashi,
Koichi Kokame, Toshiyuki
Miyata, Yoshihiro
Fujimura, Kenmei
TakaichiLong term follow up ofcongenital thrombotic
thrombocytopenic
purpura(Upshaw-Schulman
syndrome) on
hemodialysis for 19
years

BMC
Nephrol

14

156

2013

Shohei Shinozaki,
Tsuyoshi Chiba, Koichi
Kokame, Toshiyuki
Miyata, Eiji Kaneko,
Kentaro Shimokado

A deficiency of Herp, an PLoS One
endoplasmic reticulum
stress protein,suppresses
atherosclerosis in apoE
knockout mice byattenuating
inflammatory responses

8

e752492013

52 (6)783-7932013

Endocrinol
NDRG1 deficiency
attenuates fetal growth ogy
and the intrauterine
response to hypoxic
injury--

印刷中Yuka Eura, Koichi Kokame,Toshiro Takafuta,
Ryojiro Tanaka, Hikaru
Kobayashi, Fumihiro
Ishida, Shuichi
Hisanaga, Masanori
Matsumoto, Yoshihiro
Fujimura, and Toshiyuki
MiyataCandidate gene analysis Mol Genet
Genomic
using genomicMedquantitative PCR:
Identification of
ADAMTS13 large
deletions in twopatients with
Upshaw-Schulman
syndrome

-

-

印刷中

小亀浩市

ADAMTS13と血栓性血小板減少性紫斑病

循環器病研
究の進歩

34 (1)

69-75

2013

小嶋哲人

新しい経口抗凝固薬

検査と技術

41(5)

430-4342013

鈴木敦夫、小嶋哲人

新規抗凝固薬の薬力学的
特徴

呼吸と循環

61(5)

402-4092013

高木夕希、小嶋哲人

活性化プロテインC（APC） 別冊 日本
臨牀血液症
レジスタンス
候群（第2版）（III）—
その他の血
液疾患を含
めて—

新領域
別症候
群シリ
ーズ
No.23

27-30

2013

竹下享典、小嶋哲人

動脈硬化、血栓性疾患の発症と予防における抗凝
固薬の役割

動脈硬化予
防

12(2)

85-93

2013

村田萌、小嶋哲人

アンチトロンビンレジス
タンスInternatio
nal Review
ofThrombosis

8(4)

30-33

2013

小嶋哲人

血栓症・血栓性素因の臨
床検査

日本内科学
会雑誌

102
(12)

3147
-3153

2013

Riccardo Bernasconi,
Carmela Galli, Koichi
Kokame, Maurizio
Molinari

Auto-adaptive
ER-associateddegradation defines a
pre-emptive unfolded
protein response
pathway

Jacob Larkin, Baosheng
Chen, Xiao-Hua Shi,
Takuya Mishima, Koichi
Kokame, Yaacov Barak,
Yoel Sadovsky

Mol CellMizutani N, Kobayashi M,
Sobue S, Ichihara M, Ito
H, Tanaka K, Iwaki S,
Fujii S, Ito Y,
Tamiya-Koizumi K, Takagi
A, Kojima T, Naoe T,
Suzuki M, Nakamura M,
Banno Y, Nozawa Y, MurateT

Sphingosine kinase 1
expression is
downregulated during
differentiation ofFriend cells due todecreased c-MYB.

Biochim
BiophysActa. May;

1833
(5)

1006
-1016

2013

Fukuda T, Kamisato C,
Honda Y, Matsushita T,
Kojima T, Furugohri T,
Morishima Y, Shibano T

Impact of antithrombin
deficiency on efficacy
of edoxaban andantithrombin-dependent
anticoagulants,
fondaparinux,
enoxaparin, andheparin.

Thromb Res

131
(6)

540-546

2013

Okuyama E, Suzuki A,
Murata M, Ando Y, Kato I,
Takagi Y, Takagi A,
Murate T, Saito H, Kojima
T

Molecular mechanisms of J Biochem
syndecan-4
upregulation by TNF-α
in the endothelium-likeEAhy926 cells. 0.

154
(1)

41-45

2013

Suzuki N, Kunishima S,
Ikejiri M, Maruyama S,
Sone M, Takagi A, Ikawa
M, Okabe M, Kojima T,
Saito H, Naoe T,
Matsushita T

Establishment of Mouse PLoS One
Model of MYH9
Disorders:
Heterozygous R702C
Mutation Provokes
Macrothrombocytopenia
with Leukocyte
Inclusion Bodies, Renal
Glomerulosclerosis andHearing Disability.

8(8)

e711872013

Djordjevic V, Kovac M,
Miljic P, Murata M,
Takagi A, Pruner I,
Francuski D, Kojima T,
Radojkovic D

J Thromb
A novel prothrombin
Haemostmutation in two
families with prominent
thrombophilia- thefirst cases ofantithrombin
resistance in a
Caucasian population.

11
(10)

1936
-1939

2013

Yasumoto A, Madoiwa S.
Kashiwakura Y, Ishiwata
A, Ohmori T, Mizukami H,
Ozawa K, Sakata Y, Mimuro
J.

Overexpression offactor VII ameliorates
bleeding diathesis offactor VIII-deficient
mice with inhibitors.

131444-449

2013

ThrombRes

Watanabe H, Kikkawa I.,
Madoiwa S, Sekiya H,
Hayasaka S, Sakata Y.

Changes in BloodJ
Coagulation-Fibrinolys Arthroplas
is Markers By Pneumatic ty
Tourniquet During Total
Knee Joint Arthroplasty
With Venous
Thromboembolism.

Mimuro J, Mizukami H,
Shima M, Matsushita T,
Taki M, Muto S, Higasa S,
Sakai M, Ohmori T,
Madoiwa S, Ozawa
K,Sakata Y.

The prevalence ofneutralizing
antibodies against
adeno-associated virus
capsids is reduced inyoung Japaneseindividuals.

Mimuro J, Mizukami H,
Hishikawa S, Ikemoto T,
Ishiwata A, Sakata A,
Ohmori T, Madoiwa S, Ono
F, Ozawa K, Sakata Y.

Minimizing the
Mol Ther
inhibitory effect ofneutralizing antibody
for efficient gene
expression in the liverwith adeno-associatedvirus 8 vectors.

Madoiwa S, Kitajima I,
Ohmori T, Sakata Y,
Mimuro J

Distinct reactivity of
the commerciallyavailable monoclonal
antibodies of D-dimer
and plasma FDP testing
to the molecularvariants of fibrin
degradation products.

ThrombRes

Koyama K, Madoiwa S,
Tanaka S, Koinuma T, Wada
M, Sakata A, Ohmori T,
Mimuro J, Nunomiya S,
Sakata Y.

Ashizawa M, Kimura S,
Wada H, Sakamoto K, Sato
M, Terasako K, Kikuchi M,
Nakasone H, Okuda S, Kako
S, Yamazaki R, Oshima K,
Matsuura K, Ohmori T,
Madoiwa S, Nishida J,
Mimuro J, Tabei K, Sakata
Y,Kanda Y.

29

J Med Virol

569-573

2014

Epub
2013
ahead ofprint

21

318-3232013

132

457-4642013

Evaluation ofhemostatic biomarker
abnormalities thatprecede platelet countdecline in criticallyill patients withsepsis.

J Crit care 28

556-5632013

Acquired factor V
inhibitor associatedwith life-threatening
bleeding and a mixing
test result thatindicated coagulation
factor deficiency.

Hematology

300-304

2013

18

Akiyama M, Nakayama D,
Takeda S, Kokame K,
Takagi J, Miyata T

Crystal structure andenzymatic activity ofan ADAMTS-13 mutant
with the East
Asian-specific P475S
polymorphism.

J Thromb
Haemost11(7)1399-1406

2013

Mise K, Ubara Y,
Matsumoto M, Sumida K,
Hiramatsu R, Hasegawa E,
Yamanouchi M, Hayami N,
Suwabe T, Hoshino J,
Sawa N, Ohashi K,Kokame
K, Miyata T, Fujimura
Y, Takaichi K

Long term follow up ofcongenital thrombotic
thrombocytopenic
purpura(Upshaw-Schulman
syndrome) on
hemodialysis for 19
years: a case report.

BMC
Nephrol

14

156

2013

Liu W, Yin T, Okuda H,
Harada KH, Li Y, Xu B,
Yang J, Wang H, Fan X,
Koizumi A,Miyata T

ProteinS K196E
mutation, a genetic
risk factor venous
thromboembolism, islimited to Japanese.

Thromb Res

132

314-3152013

Honda S,
Shirotani-IkejimaH,
Tadokoro S, Tomiyama Y,
Miyata T

The integrin-linked
kinase-PINCH-parvincomplex supports
integrin aIIbb3
activation.

PLos ONE8(12)e854982013

Yin T, Miyata T

Dysfunction of protein J Thromb
C anticoagulant system, Thrombolys
ismain genetic risk
factor for venous
thromboembolism inNortheast Asians(review).

藤村吉博、吉田瑶子、範新萍、宮田敏行

非典型溶血性尿毒症症候群（aHUS）

Epub
2013
ahead ofprint

351(1897)-360(
1906)

2013

臨床血液

54(10)

竹尾映美、 末久悦次、 川 凝固因子インヒビター測
定法における血漿pHの安﨑富夫、 徳 雅幸、 林
定化法
貞夫、 日高 洋

日本検査血
液学会雑誌

第14巻
第1号

川﨑富夫

生体移植と医師倫理規範

生命倫理

Vol23(
通巻24
号)

31-37

2013

Yokoyama K

Involvement ofglycoprotein Ib, αIIb
β3 and von Willebrand

J BoneMarrow Res

1

102

2013

2013

factor in plateletproduction.
横山健次

多発性骨髄腫治療の最近の動向について。

東京内科医
会誌

29

37-41

2013

横山健次

【抗血栓療法 基礎知識
から最新のエビデンスまでを徹底解説!】 抗血小板薬不応症患者に対する
治療戦略

薬局

64

307-311

2013

横山健次

【血液症候群(第2版)-その他の血液疾患を含めて-】 凝固・線溶異常による出血傾向 先天性凝固
線溶異常症 血友病および類縁疾患 高分子キニノゲン欠損症

日本臨床別
冊血液症候
群

第2版
II

507-509

2013

横山健次

【血液症候群(第2版)-そ 日本臨床別の他の血液疾患を含めて 冊血液症候-】 凝固・線溶異常によ 群る出血傾向 先天性凝固
線溶異常症 血友病および類縁疾患 先天性第V、VIII因子合併欠乏症

第2版
II510-512

2013

横山健次

【血液症候群(第2版)-その他の血液疾患を含めて-】 凝固・線溶異常による出血傾向 先天性凝固
線溶異常症 血友病および類縁疾患 先天性第V因子欠乏症・異常症

日本臨床別
冊血液症候
群

第2版
II

513-515

2013

小林隆夫

ヘパリン在宅自己注射療法の適応と指針

Thrombosis
Medicine

3(4)

71-75

2013

小林隆夫

ヘパリン在宅自己注射療法の適応と導入方法

脈管学

53(No.
November)

167-170

2013

小林隆夫

研修コーナー. 妊産婦救急疾患の管理 1)妊娠悪阻に対する肺塞栓症とウェルニッケ脳症の予防

日本産科婦
人科学会誌

65(10)
別冊

N244-N2
49

2013

小林隆夫

妊婦の静脈血栓塞栓症

MedicalPractice30(9)1621-16
22

2013

小林隆夫

静脈血栓塞栓症発症の予知と早期診断心臓45(7)924-927

2013

小林隆夫

深部静脈血栓症/肺塞栓
症

臨床婦人科
産科

67(4)

73-77

2013

小林隆夫

ヘパリン在宅自己注射療法の適応と指針Internatio
nal Review
ofThrombosis

8(1)

78-81

2013

小林隆夫

肺塞栓症

周産期医学

43(1)

57-60

2013

小林隆夫

妊娠悪阻からの肺塞栓症

周産期医学

43(1)

61-63

2013

小林隆夫

妊娠時の血栓症の予防・
治療

産科と婦人
科

80(1)

77-83

2013

K Hanzawa, S Matsuoka, H requency of
Takahashi, H Takekawa, M Below-The-Knee Deep
Vein Thrombosis in
Tsuchidaet al.
Japanese Residents:
Control Study for
Residents in the Area

Internatio
nal
Angiology

Vol.
32,
Suppl
1,
No. 5

56

2013

K Hanzawa, M Ikura, T
Nakajima, T Okamoto, M
Tsuchida.

Pulmonary Embolism or
Ischemic Stroke
Increase 8-Year after
Mid Niigata Prefecture
Earthquake 2004 in the
Residents with
Asymptomatic
Below-The-Knee Deep
Vein Thrombosis.

Internatio
nal
AngiologyVol.
32,
Supple
1,
No. 5

78

2013

Koyama Y, Homma K, Fukami Two-step biochemical
M, Miwa M, Ikeda K, Ogata differential diagnosis
T, Hasegawa T, Murata M of classic
21-hydroxylase
deficiency andcytochrome P450
oxidoreductase
deficiency in Japanese
infants by GC-MS
measurement of urinary
pregnanetriolone/tetrahydroxycortisone
ratio and 11β-hydroxyandrosterone.

Clin Chem.

58（4） 741-7

2012

Igari A, Nakagawa T,
Moriki T, Yamaguchi Y,

Thromb
Res.

130

2012

Identification of
epitopes on ADAMTS13

79-83

Matsumoto M, Fujimura Y, Recognized by a panel ofmonoclonal antibodies
Soejima K, Murata M
with functional or
non-functional effects
On catalytic activity.
Koyama Y, Homma K, Miwa
M, Ikeda K, Murata M,
Hasegawa T

Measurement ofClin Chimreference intervals for Acta.
urinary free adrenal
steroid levels inJapanese newborn
infants by using stable
isotope dilution gas
chromatography/mass
spectrometry.

16;415

302-5

2012

Ono Y, Wang Y, Suzuki H,
Okamoto S, Ikeda Y,
Murata M, Poncz M,
Matsubara Y

Induction of functional Bloodplatelets from mouseand human fibroblasts
by p45NF-E2/Maf.

1;120(
18)

3812-212012

Ishizawa J, Mori T,
Tsukada Y, Matsuki E,
Yokoyama K, Shimizu T,
Sugita K, Murata M, Iwata
S, Okamoto S.

Recurrent cellulitis
due to Helicobacter
cinaedi after
chemotherapy formalignant lymphoma.

RinshoKetsueki.

53(6)

623-7

2012

Tsukada Y, Hattori Y,
Nakajima H, Yokoyama K,
Murata M, Shimizu N,
Kondo N, Okamoto S

B-cell acute
Rinsholymphoblastic leukemia Ketsueki.
developed 5 years after
autologous stem celltransplantation for
multiple myeloma.

53(2)219-23

2012

Yokoyama K, Kojima T,
Sakata Y, Kawasaki T,
Tsuji H, Miyata T,
Okamoto S, Murata M

A survey of the clinical Clin Appl
Thrombcourse and management
Hemost.
of Japanese patients
deficient in natural
anticoagulants.

18(5)506-13

2012

Arai T, Kawamura A,
Matsubara Y, Yokoyama K,
Ikeda Y, Fukuda K, Murata
M

Effect of chronic
kidney disease onplatelet reactivity to
dual-antiplatelet
therapy inpatientstreated withdrug-eluting stents.

Heart
Vessels.

27(5)

480-5

2012

Yokoyama K, Murata M,
Ikeda Y, Okamoto S

Incidence and risk
factors for developing
venous thromboembolism

Thromb
Res.

130(1)

7-11

2012

in Japanese withdiffuse large b-cell
lymphoma.

Koyama Y, Homma K, Fukami Two-step biochemical
M, Miwa M, Ikeda K, Ogata differential diagnosis
T, Hasegawa T, Murata M of classic
21-hydroxylase
deficiency andcytochrome P450
oxidoreductase
deficiency in Japanese
infants by GC-MS
measurement of urinary
pregnanetriolone/tetrahydroxycortisone
ratio and 11β-hydroxyandrosterone.

Clin Chem.

TransplMori T, Nakamura Y, Kato Fungemia due to
InfectRhodotorulaJ, Sugita K, Murata M,
Dis.
mucilaginosa after
Kamei K, Okamoto S
allogeneic
hematopoietic stem celltransplantation.

58(4)

741-7

2012

14(1)

91-4.

2012

血液フロン
ティア

22（4） 17（483） 2012
－20
（486）

和田英夫、登勉、川杉和夫、 ＤＩＣ診断基準の評価並
関義信、久志本成樹、岡本 びに検査項目のカットオ
フ値の検討
好司、村田満臨床化学

41（2） 166-173

中谷綾、村田満

ビジュアル
栄養療法
「メカニズ
ムからわか
る治療戦
略」

村田満

序～止血凝固障害ガイド
ラインupdateにあたって
～

血液疾患

「貧血」

158－
168

2012

石澤丈、森毅彦、塚田唯子、 悪性リンパ腫に対する化
松本絵里、横山健次、清水 学療法後に発症し再燃を
雄之、杉田香代子、村田満、 繰り返したHelicobacter
cinaedi による蜂窩織炎
岩田 敏、岡本真一郎

臨床血液53（6） 623-627

2012

猪狩敦子、村田満Internatio
nal Review
ofThrombosis

7（1）

2012

POCT(point of caretesing)78-80

医学と自然中川央充、小口修司、松本 ビトロスHbA1c測定値に幸子、石橋みどり、菊池春 おける日常検査法（HLC‐
723G8）との整合性検討：
人、村田満
ビトロスHbA1c測定値における日常検査法（HLC‐
723G8）との整合性検討

67（2） 271-277

2012

120(7)

1499-15
092012

Kiyomizu K, Kashiwagi H,
Nakazawa T, Tadokoro S,
Honda S, Kanakura Y,
Tomiyama Y.

Blood
Recognition of highly
restricted regions inthe β-propeller domainof αIIb by
platelet-associatedanti-αIIbβ3
autoantibodies inprimary immune
thrombocytopenia.

冨山佳昭

特発性血小板減少性紫斑病(ITP)治療の参照ガイ
ド.

血液フロン
ティア

22(4)

487-493

2012

冨山佳昭

特発性血小板減少性紫斑病.

内科

109(6)

1111-11
14

2012

冨山佳昭

血小板増加薬としてのト
ロンボポエチン受容体作動薬とその使い方.

最新医学

67(9)

124-129

2012

冨山佳昭

新規薬剤による免疫性血小板減少症の治療.

日本内科学
会雑誌

101(9)

2725-27
32

2012

冨山佳昭

P2Y12受容体に関する遺伝子関連検査.

血栓止血誌

23(5)

450-4562012

柏木浩和，冨山佳昭.

血栓形成の分子機構; 血小板機能異常症の解析からみた最近の進歩.

PharmaMedica

30(4)

9～14

2012

藤村欣吾, 宮川義隆, 倉田義之, 桑名正隆, 冨山
佳昭, 村田満.

成人特発性血小板減少性
紫斑病治療の参照ガイド
2012年版.

臨床血液

53(4)

433-4422012

Kuwana M, and Okazaki Y

Quantification ofAnn.
circulating
Rheum.
endothelial progenitor Dis.
cells in systemicsclerosis: a directcomparison of protocols

71(4)617-6202012Nishimoto T, Satoh T,
Critical role ofTakeuchi T, Ikeda Y, and CD4+CD25+ regulatory T
cells in preventing
Kuwana M
murineautoantibody-mediatedthrombocytopenia

Exp.
Hematol.

40(4)279-289

2012

71(5)

710-7132012

Ichimura Y, Matsushita
T, Hamaguchi Y, Kaji K,
Hasegawa M, Tanino Y,
Inokoshi Y, Kawai K,
Kanekura T, Habuchi M,
Igarashi A, Sogame R,
Hashimoto T, Koga T,
Nishino A, Ishiguro N,
Sugimoto N, Aoki R, Ando
N, Abe T, Kanda T, Kuwana
M, Takehara K, andFujimoto M

Ann.
Anti-NXP2
autoantibodies in adult Rheum.
Dis.
patients with
idiopathic
inflammatory
myopathies: possible
association withmalignancy

Mitsunaga S, Suzuki Y,
Kuwana M, Sato S, Kaneko
Y, Homma Y, Narita A,
Kashiwase K, Okudaira Y,
Inoue T, Kulski JK, andInoko H

Associations between
six classical HLA lociand rheumatoid
arthritis: acomprehensive analysis

TissueAntigens.

80(1)

16-25

2012

Suzuki S, Hayashi Y,
Kuwana M, Tsuburaya R,
Suzuki N, and Nishino I

Myopathy associatedwith antibodies tosignal recognition
particle: diseaseprogression andneurological outcome

Arch.
Neurol.

69(6)728-732

2012

Koga T, Fujikawa K, Horai
Y, Okada A, Kawashiri S,
Iwamoto N, Suzuki T,
Nakashima Y, Tamai M,
Arima K, Yamasaki S,
Nakamura H, Origuchi T,
Hamaguchi Y, Fujimoto M,
Ishimatsu Y, Mukae H,
Kuwana M, Kohno S, Eguchi
K, and Kawakami A

The diagnostic utilityof anti-melanoma
differentiation-associated gene 5 antibody
testing for predicting
the prognosis ofJapanese patients withdermatomyositis

Rheumatolo
gy

51(7)

1278-1284

2012

Satoh T, Tanaka Y,
Okazaki Y, Kaburaki J,
Ikeda Y, and Kuwana M

Heparin-dependent and-independentanti-platelet factor 4
autoantibodies inRheumatolo
gy

51(9)

1721-1728

2012

patients with systemic
lupus erythematosus
Shirai Y, Yasuoka H,
Okano Y, Takeuchi T,
Satoh T, and Kuwana M

Clinicalcharacteristics andsurvival of Japanesepatients withconnective tissue
disease and pulmonary
arterial hypertension:a single-center cohort

Rheumatology

51(10)

1846-18
54

2012

Gono T, Kawaguchi Y,
Kuwana M, Sugiura T,
Furuya T, Takagi K,
Ichida H, Katsumata Y,
Hanaoka M, Ota Y, andYamanaka H

Association of
HLA-DRB1*0101/*0405
with susceptibility to
anti-melanoma
differentiation-associated gene 5
antibody-positive
dermatomyositis in theJapanese population

Arthritis
Rheum.

64(11)

3736-37
40

2012

Histol.
Yamaguchi Y, and Kuwana M Proangiogenic
hematopoietic cells of Histopatho
monocytic origin: roles l.
in vascularregeneration andpathogenic processes ofsystemic sclerosis28(2)175-183

2013

Nishimoto T, Satoh T,
Simpson EK, Ni H, andKuwana M

Predominantautoantibody response
to GPIb/IX in a
regulatory
T-cell-deficient mousemodel for immune
thrombocytopenia

J. Thromb.
Haemost.

藤村欣吾

抗血栓薬・血液疾患治療薬―特発性血小板減少性
紫斑病

薬局

63

76-81

2012

藤村

欣吾

成人特発性血小板減少性
紫斑病治療の参照ガイド
2012 年版

臨床血液53433-442

2012

藤村

欣吾

特発性血小板減少性紫斑病のヘリコバクター・ピ
ロリ除菌療法は有効か

血液フロン
ティア

22

1702－
1706

2012

特発性血小板減少性紫斑

血液フロン

22

1702－

2012

藤村欣吾

病のヘリコバクター・ピ
ロリ除菌療法は有効か

ティア

Yagi H, Matsumoto M,
Fujimura Y.

Paradigm shift ofchildhood TTP withsevere ADAMTS13
deficiency.

La Presse
Médicale

41

E137-15
5

2012

Takaya H, Uemura M,
Fujimura Y, Matsumoto M,
Matsuyama T, Kato S,
Morioka C, Ishizashi H,
Hori Y, Fujimoto M,
Tsujimoto T, Kawaratani
H, Kurumatani N, Fukui H.

ADAMTS13 activity may
Hepatology
predict the cumulative Res
survival of patientswith liver cirrhosis incomparison with theChild-Turcotte-Pughscore and the Model for
End-Stage Liver Diseasescore.

42459-475

2012

Koyama N, Matsumoto M,
Tamaki S, Yoshikawa M,
Fujimura Y, Kimura H.

Eur Respir
Reduced larger vonJ
Willebrand factor
multimers at dawn in OSA
plasmas reflect
severity of apnetic
episodes.

40

657-6642012

Matsumoto M, Bennett CL,
Qureshi Z, Isonishi A,
Hori Y, Hayakawa M,
Yoshida Y, Yagi H,
Fujimura Y.

Acquired idiopathic
PLoS ONEADAMTS13 activity
deficient thrombotic
thrombocytopenic
purpura in a populationfrom Japan.

e330292012

Tanabe S, Yagi H, Kimura
T, Isonishi A, Kato S,
Yoshida Y, Hayakawa M,
Matsumoto M, Ohtaki S,
Takahashi Y, Fujimura Y.

Two newborn-onset
patients of UpshawSchulman syndrome with
distinct subsequentclinical courses.

96789-797

2012

Yagi H, Yamaguchi N,
Shida Y, Hayakawa M,
Matsumoto M, Sugimoto M,
Wada H, Tsubaki K,
Fujimura Y.

Cilostazol
Eur J
down-regulates the
Pharmacolheight of mural platelet
thrombi formed under ahigh shear-rate flow in
the absence of ADAMTS13.

691

151-155

2012

Yoshida K, Wada H,
Hasegawa M, Wakabayashi
HMatsumoto T,
Shimokariya Y, Noma K,
Yamada N, Uchida A,
Nobori T, Sudo A

Increased fibrinolysis
increases bleeding inorthopedic patients
receiving prophylactic
fondaparinux

95(2)160-166

2012

Int J
Hematol

Int J
Hematol

1706

Ikejiri M, Shindo A, Ii
Y, Tomimoto H, Yamada N,
Matsumoto T, Abe Y,
Nakatani K, Nobori T,
Wada H

Frequent association of Int J
Hematol
thrombophilia in
cerebral venous sinus
thrombosis

95(3)257-2622012

Habe K, Wada H, Ito-Habe
N, Hatada T, Matsumoto T,
Ohishi K, Maruyama K,
Imai H, Mizutani H,
Nobori T

Thromb Res
Plasma ADAMTS13, vonWillebrand Factor (VWF)and VWF Propeptide
Profiles in Patientswith DIC and RelatedDiseases

129(5)

598-602

2012

Masayuki Fujioka,
Takafumi Nakano,Kazuhide Hayakawa,Keiichi Irie, Yoshiharu
Akitake, Yuya Sakamoto,Kenichi Mishima, Carl
Muroi, Yasuhiro
Yonekawa, Fumiaki Banno,
Koichi Kokame, Toshiyuki
Miyata, Kenji Nishio,
Kazuo Okuchi, Katsunori
Iwasaki, Michihiro
Fujiwara, Bo K. Siesjo

ADAMTS13 gene deletion
enhances plasma
high-mobility groupbox1 elevation andneuroinflammation inbrainischemia-reperfusion
injuryNeurol Sci

33

1107-1115

2012

Yuka Eura, Hiroji
Yanamoto, Yuji Arai,
Tomohiko Okuda,
Toshiyuki Miyata, Koichi
KokameDerlin-1 deficiency isembryonic lethal,
Derlin-3 deficiency
appears normal, andHerp deficiency is
intolerant to glucose
load and ischemia inmice

PLoS One7 (3)e34298

2012

Takashi Sato, Yasuhiro
Sako, Misato Sho, Mamiko
Momohara, Mary Ann
Suico, Tsuyoshi Shuto,
Hideki Nishitoh, Tsukasa
Okiyoneda, Koichi
Kokame, Masayuki Kaneko,
Manabu Taura, Masanori
Miyata, Keisuke Chosa,Tomoaki Koga, Saori
Morino-Koga, Ikuo Wada,
Hirofumi Kai

Mol Cell
STT3B-dependent
posttranslational
N-glycosylation as asurveillance system forsecretory protein

47 (1)

99-110

2012

152
(3)

251-258

2012

ADAMTS13 safeguards the Thromb
Haemostmyocardium in a mousemodel of acute
myocardial infarction

108
(6)

1236-1238

2012

宮田敏行, 小亀浩市, 秋
山正志, 坂野史明, 中山
大輔, 武田壮一

ADAMTS13研究の最先端

臨床血液53 (7)

672-6792012

小亀浩市,宮田敏行

小胞体ストレスと循環器
疾患

生体の科学

63 (5)

390-391

2012

小亀浩市

重度高ホモシステイン血症マウスは血栓傾向を示
さないというパラドック
ス

日本血栓止
血学会誌

23 (4)

416

2012

宮田敏行, 小亀浩市,
小久保喜弘

先天性ADAMTS13欠損症

臨床検査

Suzuki A, Nakashima D,
Miyawaki Y, Fujita J,
Maki A, Fujimori Y,
Takagi A, Murate T,
Teranishi M, Matsushita
T, Saito H, Kojima T

A novel ENG mutation
causing impaired
co-translational
processing of endoglin
associated withhereditary hemorrhagictelangiectasia.

Thromb Res. 129(5)e200-20
82012

Miyawaki Y, Suzuki A,
Fujita J, Maki A, Okuyama
E, Murata M, Takagi A,
Murate T, Kunishima S,
Sakai M, Okamoto K,
Matsushita T, Naoe T,
Saito H, Kojima T

Thrombosis from aprothrombin mutation
conveying antithrombin
resistance.

N Engl J
Med.

366

2390
-2396

2012

Fujita J, Miyawaki Y,
A possible mechanism for J Thromb
Suzuki A, Maki A, Okuyama Inv22-related F8 large Haemost.

10
(10)

2099
-2107

2012

Yongchol Shin, Masashi
Akiyama, Koichi Kokame,
Kenji Soejima, Toshiyuki
MiyataBinding of vonWillebrand factor
cleaving protease
ADAMTS13 to
Lys-plasmin(ogen)

Masaaki Doi, Hideto
Matsui, Yukiji Takeda,
Yoshihiko Saito, Maiko
Takeda, Yasunori
Matsunari, Kenji Nishio,
Midori Shima, Fumiaki
Banno, Masashi Akiyama,
Koichi Kokame, Toshiyuki
Miyata, and Mitsuhiko
Sugimoto

J BiochemE, Murata M, Takagi A,
Murate T, Suzuki N,
Matsushita T, Saito H,
Kojima T

deletions in severe
hemophilia a patientswith high responding
factor VIII inhibitors.

Mimuro J, Mizukami H,
Hishikawa S, Ikemoto T,
Ishiwata A, Sakata A,
Ohmori T, Madoiwa S, Ono
F, Ozawa K, Sakata Y.

Minimizing the
Mol Ther.
inhibitory effect ofneutrajizing antibody
for efficient gene
expression in the liverwith adeno-associatedvirus 8 vectors.

21(2)Makino N, Madoiwa S,
Ohmori T, Katoh K,
Ookawara S, Kanazawa T,
Matsuo O, Ichikawa M,
Mimuro J, Ichimura K,
Sakata Y.

Tissue plasminogenactivator deficiency
promotes early phaseregeneration in theolfactory epithelium
after bulbegtomy.

Int Forum
Allergy
Rhinol.

In
press

Kashiwakura Y, Mimuro J, Porcine model ofhemophilia a.
Onishi A, Iwamoto M,
Madoiwa S, Fuchimoto D,
Suzuki S, Suzuki M,
Sembon S, Ishiwata A,
Yasumoto A, Sakata A,
Ohmori T, Hashimoto M,
Yazaki S, Sakata Y.

PLoS One.

Makino N. Ookawara S.
Madoiwa S. Ohta Y.
Ishikawa T. Katho K.
Takigami S. Kanazawa T.
Matsuo O. Ichikawa M.
Mimuro J. Sakata Y.
Ichimura K.

Morphologicalassessment of theluminal surface ofolfactory epithelium inmice deficient in tissue
plasminogen activator
following bulbectomy.

The
Journal of
Laryngology &Otology.

Hosoya Y. Matsumura M.
Madoiwa S. Zuiki T.
Matsumoto S. Nunomiya S.
Lefor A. Sata N. Yasuda
Y.

Acquinred hemophilia A
caused by factor VIII
inhibitors:report of acase .

Surg Today.

Suzuki S. Iwamoto M.
I12rg gene-targeted
Saito Y.Fuchimoto D.
severe combined
Sembon S.Suzuki M.
immunodeficiency pigs.
Mikawa S. Hashimoto M.
Aoki Y. Najima Y. Takagi
S. Suzuki N. Suzuki E.
Kubo M. Mimuro J.
Kashiwakura, Y. Madoiwa

Cell StemCell.

318-323

2012

7(11)

e49450

2012

126
(11)

1114-1120

2012

14;10(
6)

753-758

2012

S. Sakata Y. Perry AC.
Ishikawa F. Onishi A.
Kashiwakura Y. Ohmori T.
Mimuro J. Yasumoto A.
Ishiwata A. Sakata A.
Madoiwa S. Inoue M.
Hasegawa M. Ozawa K.
Sakata Y.

Intra-articular
injection ofmesenchymal stem cells
expressing coagulation
factorameliorates
hemophilic arthropathy
in factor
VIII-deficient mice.

J Thromb
Haemost.

10(9)1802-18
13

2012

Norimatsu, Y. Ohmori T.
Kimura A. Madoiwa S.
Mimuro J. Seichi A.
Yatomi Y. Hoshino Y.
Sakata Y.

FTY720 improves
functional recovery
after spinal cord
injury by primarily
nonimmunomodulatory
mechanisms.

Am J
Pathol.

180(4)

1625-1635

2012

Ohmori T. Yano Y. Sakata
A. Ikemoto T. Shimpo M.
Madoiwa S. Katsuki T.
Mimuro J. Shimada K.
Kario K. Sakata Y.

Lack of association
Thromb Res. 29(4)between serum
paraoxonase-1 activity
and residual platelet
aggregation during dual
anti-platelet therapy.

36-40

2012

Madoiwa S. Kobayashi E.
Kashiwakura Y. Sakata A.
Yasumoto A. Ohmori T.
Mimuro J. Sakata Y.

Immune response against Haemophili
serial infusiona.
offactor VIII antigen
through an implantablevenous-access device
system in haemophilia A
mice.

18(3)

e323-33
0

2012

Kita T, Banno F, Yanamoto Large infarct and highmortality by cerebral
H, Nakajo Y, Iihara K,
ischemia in mice
Miyata T
carrying the factor V
Leiden mutation.

J Thromb
Haemost.

10(7)1453-1455

2012

Shin Y, Akiyama M, Kokame Binding of vonWillebrand factor
K, Soejima K, Miyata T
cleaving protease
ADAMTS13 to
Lys-plasmin(ogen).

J Biochem.

152
(3)

251-258

2012

川﨑富夫

法学的意思と意志の異同と患者の自己決定権

生命倫理

通巻23
号

42-50

2012

榛沢和彦

避難所における肺塞栓症・深部静脈血栓症

日本医師会
雑誌

141巻1
号

84-85

2012

榛沢和彦

避難環境と深部静脈血栓症—東日本大震災による検診結果から-

臨床血液

53号10
巻

1730-36

2012

榛沢和彦

新潟県中越地震6年後のDVT検診結果：DVTと高血
圧との関連

静脈学

23 号
4巻

315-320

2012

Mayumi Ono,YumikoMtsubara,Toshiro
shibano,Yasuo Ikeda,＆
Mitsuru Mutara

GSK-3βnegatively
Platelets
regulates
megakaryocyte
differentiation andplatelet production
from primary human bonemarrow cells in vitro.

22(3)196-2032011

YusukeYamaguchi,Takanori
Moriki,Atsuko
Igari,Terumichi
Nakagawa,Hideo
Wada,Masanori
Matsumoto,Yoshihiro
Fujimura, Mitsuru Mutara

Epitope analysis of
autoantibodies to
ADAMTS13 in patientswith acquired
thrombocytopenic
purpura☆.

Thrombosis
Research123

169-173

2011

Torita S, Suehisa E,
Kawasaki T, Toku M, Takeo
E, Tomiyama Y, Nishida S,
Hidaka Y.

Development of a newmodified Bethesda
method for coagulation
inhibitors: the Osaka
modified Bethesda
method.

Blood
CoagulFibrinolys
is22

185-189

2011

Kurata Y, Fujimura K,
Kuwana M, Tomiyama Y,
Murata M.

Epidemiology of primary Int J
immune thrombocytopenia Hematolin children and adults
in Japan: apopulation-based study
and literature review.

93(3)329-335

2011

Kamae T, Kiyomizu K,
Nakazawa T, Tadokoro S,
Kashiwagi H, Honda S,
Kanakura Y, Tomiyama Y.

Bleeding tendency andJ Thromb
impaired platelet
Haemostfunction in a patient
carrying a heterozygous
mutation in thethromboxane A2 receptor.

9(5)1040-1048

2011

Kunishima S, Kashiwagi H,
Otsu M, Takayama N, Eto K,
Onodera M, Miyajima Y,
Takamatsu Y, Suzumiya J,
Matsubara K, Tomiyama Y,

Heterozygous ITGA2B
Blood
R995W mutation inducing
constitutive activationof the αIIbβ3 receptor
affects proplatelet

117(20)2479-2484

2011

Saito H.

formation and causes
congenital
macrothrombocytopenia.

KurataY. ,Fujimura K,
et al

Epidemiology of primary Int. J.
immune thrombocytopenia Hematol.
in children and adults
in Japan : apopulation-based study
and literature review.

93329-335

2011

Yamaguchi M., FujimuraK., et al

Mislocalization or low
expression of mutated
Shwachman-Bodian-Diamo
nd syndrome protein.

Int. J.
Hematol.

94

54-62

2011

Kobayashi I, Okura Y,
Yamada M, Kawamura N,
Kuwana M, and Ariga T

Anti-melanoma
J. Pediatr. 158(4)differentiation-associated gene 5 antibody isa diagnostic andpredictive marker forinterstitial lungdiseases associatedwith juvenile
dermatomyositis

675-677

2011

Hoshino K, Satoh T,
Association of
Kawaguchi Y, and Kuwana M Hepatocyte Growth
Factor promoter
polymorphism withseverity ofinterstitial lungdisease in Japanesepatients with systemicsclerosis

Arthritis
Rheum.

63(8)2465-24
72

2011

Suzuki S, Utsugisawa K,
Iwasa K, Satoh T, Nagane
Y, Yoshikawa H, Kuwana M,
and Suzuki N

Autoimmunity toendoplasmic reticulum
chaperone GRP94 inmyasthenia gravis

J.
Neuroimmunol.

237(12)

87-92

2011

Takahashi H, Kouno M,
Nagao K, Wada N, Hata T,
Nishimoto S, Iwakura Y,
Yoshimura A, Yamada T,
Kuwana M, Fujii H, Koyasu
S, and Amagai M

Desmoglein 3-specific
J. Clin.
CD4+ T cells induce
Invest.
pemphigus vulgaris andinterface dermatitis inmice

121(9)

3677-36
88

2011

Furuya Y, and Kuwana M

Effect of bosentan on
systemicsclerosis-associated38(10)

2186-21
92

2011

J.
Rheumatol.

interstitial lungdisease ineligible for
cyclophosphamide
therapy: a prospective
open-label study
Hasegawa M, Asano Y, Endo
H, Fujimoto M, Goto D, Ihn
H, Inoue K, Ishikawa O,
Kawaguchi Y, Kuwana M,
Muro Y, Ogawa F, Tanaka S,
Takehara K, and Sato S

Investigation ofRheumatolo
prognostic factors for gyskin sclerosis and lungfunction in Japanesepatients with earlysystemic sclerosis: amulticenter prospective
observational study

51(1)129-133

2012

Hattori H, Suzuki S,
IntracranialJ.
Neurosci.
Okazaki Y, Suzuki N, and transplantation of
monocyte-derived
Res.
Kuwana M
multipotential cells
enhances recovery after
ischemic stroke in rats90(2)479-488

2012

Yamaguchi M. Fujimura
K.Kanegane
H.Toga-Yamaguchi
H.Chopra R.
OkamuraN.

Mislocalization or low
expression of mutated
Shwachman-Bodian-Diamo
nd syndrome protein.

Int. J.
Hematol.

94

54-62

2011

Fujimura Y, Matsumoto M,
Isonishi A, Yagi H,
Kokame K,
Soejima K, Murata M,
Miyata T.

Natural history ofUpshaw-Schulman
syndrome based on
ADAMTS13 gene analysis
in Japan.

J Thromb
Haemost.

9283-3012011

50

643-647

2011

Akiyama R, Komori I,
H1N1 influenza (swine
Intern Med
Hiramoto R, Isonishi A, flu)-associatedMatsumoto M, Fujimura Y. thrombotic
microangiopathy with amarkedly high plasma
ratio of von Willebrandfactor to ADAMTS13.
Uemura M, Fujimura Y, Ko Determination of
Int J
Hapatol
S, Matsumoto M, Nakajima ADAMTS13 and Its
Clinical SignificanceY, Fukui H.
for ADAMTS13
supplementation therapy
to improve the survivalof patients withdecompensated livercirrhosis.

Takemitsu T, Wada H,
Hatada T, Ohmori Y,
Ishikura K, Takeda T,
Sugiyama T, Yamada N,
Maruyama K,Katayama N,
Isaji S, Shimpo H,
Kusunoki M, Nobori T

Prospective evaluation Thrombof three different
Haemost.
diagnostic criteria fordisseminatedintravascular
coagulation

105(1)

40-44

2011

Ito-Habe N, Wada H,
Matsumoto T, Ohishi K,
Toyoda H, Ishikawa E,
Nomura S, Komada Y, Ito M,
Nobori T, Katayama N:

Elevated Von
Int J
Willebrandfactor
Hematol
propeptide for the
diagnosis of thrombotic
microangiopathy and forpre-dicting a pooroutcome.

93(1)

47-52

2011

Kawasugi K, Wada H,
Hatada T, Okamoto K,
Uchiyama T, Kushimoto S,
Seki Y, Okamura T,
Nobori T

Japanese Society ofThrombosis
Hemostasis/DIC
subcommittee.
Prospective evaluationof hemostatic
abnormalities in overt
DIC due to various
underlying diseases.

Thromb Res. 128(2)186-902011

Yoshida K, Wada H,
Hasegawa M, Wakabayashi
H, Ando H, Oshima
S,Matsumoto T,
Shimokariya Y, Noma K,
Yamada N, Uchida A,
Nobori T, Sudo A

Monitoring for anti-Xa
activity forprophylactic
administration of
fondaparinux inpatients withartificial joint
replacement.

Int J
Hematol.

355-3602011

Habe K, Wada H, Ito-Habe
N, Hatada T, Matsumoto T,
Ohishi K, Maruyama K,
Imai H, Mizutani H,
Nobori T

Plasma ADAMTS13, vonThromb Res
Willebrand Factor (VWF)and
VWF Propeptide Profiles
in Patients with DIC and
Related Diseases.

Yoshida K, Wada H,
Hasegawa M,Wakabayashi
H, Matsumoto T,
Shimokariya Y, Noma K,
Yamada N, Uchida A,
Nobori T, Sudo A

Increased fibrinolysis
increases bleeding inorthopedic patients
receiving prophylactic
fondaparinux.

94(4)

2011

Int J
Hematol

2011

Ikejiri M, Shindo A, Ii Y, Frequent association of Int J
Tomimoto H, Yamada N,
Hematol
thrombophilia in

2011

Matsumoto T, Abe Y,
Nakatani K, Nobori T,
Wada H

cerebral venous sinus
thrombosis.

Yuji Shono, Chiaki
Yokota, Yuji Kuge,
Shinsuke Kido, Akina
Harada, Koichi Kokame,
Hiroyasu Inoue, Mariko
Hotta, Kenji Hirata,
Hideo Saji, Nagara
Tamaki, Kazuo Minematsu

Gene expression
associated with anenriched environment
after transient focal
ischemia

Brain Res

1376

60-65

2011

Megumi Hatori, Tsuyoshi
Hirota, Michiko Iitsuka,
Nobuhiro Kurabayashi,
Shogo Haraguchi, Koichi
Kokame, Ryuichiro Sato,
Akira Nakai, Toshiyuki
Miyata, Kazuyoshi
Tsutsui, and Yoshitaka
FukadaProc Natl
Light-dependent andAcad Sci
circadianUSA
clock-regulated
activation of SREBP,XBP1 and HSF pathways in
the pineal gland

108
(12)

4864-48
69

2011

Kenji Hirata, Yuji Kuge,
Chiaki Yokota, Akina
Harada, Koichi Kokame,
Hiroyasu Inoue, Hidekazu
Kawashima, Hiroko
Hanzawa, Yuji Shono,
Hideo Saji, Kazuo
Minematsu, and Nagara
Tamaki

Gene and protein
analysis of brain
derived neurotrophic
factor expression in
relation toneurological recovery
induced by an enrichedenvironment in a rat
stroke model

Neurosci
Lett

495
(3)

210-215

2011

Koichi Kokame, Toshiyuki
Sakata¸ Yoshihiro
Kokubo, and Toshiyuki
Miyatavon Willebrand
J Thromb.
factor-to-ADAMTS13
Haemostratio increases with age
in a Japanese population

9 (7)1426-1428

2011

Toshihiro Marutani,
Tomoji Maeda, Chiaki,
Tanabe, Kun Zou, Wataru
Araki, Koichi Kokame,
Makoto Michikawa, andHiroto Komano

ER-stress-inducible
Biochim
Herp, facilitates the
Biophysdegradation of immature Acta
nicastrin

1810
(8)

790-798

2011

Hitomi Yamamoto, Koichi
Kokame, Tomohiko Okuda,
Yukako Nakajo, Hiroji
Yanamoto, and Toshiyuki
MiyataNDRG4 protein-deficient J Biol Chem 286(29)
mice exhibit spatial
learning deficits andvulnerabilities tocerebral ischemia

26158-26165

2011

Koichi Kokame, Yoshihiro Polymorphisms andJ Thrombmutations of ADAMTS13 in Haemost
Kokubo, and Toshiyuki
Japanese population and
Miyataestimation of the numberof patients with Upshaw–
Schulman syndrome

9 (8)1654-16
56

2011

NeurochemInt

59 (1)

21-27

2011

Toshiaki Takeichi, Mika The effect of Ndrg2
Takarada-Iemata, Koji
expression on
Hashida, Hirofumi Sudo, astroglial activation
Tomohiko Okuda, Koichi
Kokame, Taku Hatano,
Masashi Takanashi,
Sayaka Funabe, Nobutaka
Hattori, Osamu Kitamura,
Yasuko Kitao, and Osamu
Hori
Reiko Neki, Tomio Fujita,
Koichi Kokame, Isao
Nakanishi, Masako
Waguri, Yuzo Imayoshi,
Noriyuki Suehara,
Tomoaki Ikeda, andToshiyuki Miyata

Genetic analysis of
Int J
patients with deep vein Hematol
thrombosis during
pregnancy andpostpartum

94 (2)

150-155

2011

Miyata T, Hamasaki N,
Wada H, Kojima T:

Venous thromboembolism
and a race-specificgenetic variation,
protein S K196E, inJapanese.

J Thromb
Haemost.

10(2)319-320

2011

Saito H, Matsushita T,
Kojima T,

Historical perspective J Thromb
and future direction of Haemost.
coagulation research.

Suppl
1

352-363

2011

Watanabe, H., Madoiwa,
S., Sekiya, H., Nagahama,Y., Matsuura, S.,
Kariya ,Y., Ohmori ,T.,
Mimuro, J., Hoshino, Y.,
Hayasaka ,S., Sakata, Y.

Predictive blood
Thromb Res. 128(6)coagulation markers forearly diagnosis ofvenous thromboembolism
after total knee joint
replacement.

Dokai, M., Madoiwa, S,
Yasumoto ,A.,
Kashiwakura, Y.,
Ishiwata, A., Sakata, A.,
Makino, N., Ohmori ,T.,
Mimuro, J., Sakata, Y.

Local regulation ofneutrophil elastaseactivity by endogenousant i t r yps i n i n
l i popol ys acchar i de
primed hematologicalcells.

Thromb Res. 128.

2011
e137-143

283-292.

2011

Madoiwa, S.,Tanaka, H.,
Nagahama, Y., Dokai, M.,
Kashiwakura ,Y. ,Ishiwata, A., Sakata, A.,
Yasumoto, A., Ohmori, T.,
Mimuro, J., Sakata, Y.

Degradation ofThromb Res. 127
cross-linked fibrin byleukocyte elastase asalternative pathway forplasmin-mediatedfibrinolysis insepsis-induced
disseminatedintravascular
coagulation.

S. Kameda, T. Sakata, Y.
Kokubo, M. Mitsuguro, A.
Okamoto, M. Sano,T.
MiyataAssociation of platelet J
aggregation with lipid Atheroscle
levels in the Japanese rThromb.
population: the Suita
Study.

R. Neki, T. Fujita, K.
Kokame, I. Nakanishi, M.
Waguri, Y. Imayoshi, N.
Suehara, T. Ikeda, T.
MiyataGenetic analysis of
Int J
patients with deep vein Hematol.
thrombosis during
pregnancy andpostpartum.

Ando M, Fukuda I, Ito M,
Kobayashi T, Masuda M,
Miyahara Y, Nakanishi N,
Niwa K, Ohgi S, Tajima H;
JCS Joint Working Group.

Guidelines for the
diagnosis, treatment
and prevention of
pulmonarythromboembolism anddeep vein thrombosis(JCS 2009) – digest
version-.

Yoshiyuki kurata,kingo
fujimura,Masataka
Kuwana,Yoshiaki
Tomiyama,Mitsuru Murata

山口雄亮、村田村田満

満

猪狩敦子、村田満

349-355

2011

18(7)

560-567

2011

94(2)

150-155

2011

75(5)

1258-1281

2011

Epidemiology of primary Int J
Hematol.
immunethrombocytopenia inchildren and adults inJapan : apopulation-based stuby
and literature review.

93329-3352011

抗血小板薬の薬効評価法
の現状

循環器内科

69（2） 177-182

2011「総論 今、なぜ「血小
板」か」

特集 血小
板-核のな
“細胞”

43（2） 48-50

2011

抗血小板療法モニタリン
グ

抗血栓療法
の新潮流―
作用機序に
基づく治療

Circ J2011

戦略 抗血栓療法の進歩
西山美保、林 悟、兜森
多項目自動血球分析装置 臨床病理修、山西八郎、末久悦次、 XE－5000 を用いた幼若血
倉田義之、柏木浩和、冨山 小板比率（IPF%）測定における抗凝固剤と保存温
佳昭
度の影響－抗凝固剤 CTAD と室温保存の有用性－

59(5)452-458

2011

冨山佳昭

特発性血小板減少性紫斑病 - 最近の話題

43(2)

18-21

2011

冨山佳昭

血小板の活性化機能：ADP 人工血液の果たす役割18

151-153

2011

冨山佳昭

特発性血小板減少性紫斑病 - 最近の話題

Medicament
News

2049

5-6

2011

冨山佳昭

P2Y12 受容体阻害抗血小板 カレントテ
薬
ラピー

29(6)

59-63

2011

冨山佳昭

今後の抗血小板療

血栓と循環

19

305-310

2011

冨山佳昭

特発性血小板減少性紫斑病(ITP)の治療戦略と血小板増加薬の適応

血液フロン
ティア

21(7)

997-100
3

2011

冨山佳昭

特発性血小板減少性紫斑病(ITP)の病態と新規治療法

SRL 宝函

32(2)

33-42

2011

冨山佳昭

トロンボポエチン受容体作動薬による難治性 ITP
の治療

臨床血液

52(8)

627-632

2011

冨山佳昭

新規抗血小板薬の開発

脈管学

51

301-307

2011

藤村欣吾

特発性血小板減少性紫斑 検査と技術
病（ITP）に対するヘリコバクターピロリ菌除菌療
法

39

31―36

2011

小亀浩市

日本人のADAMTS13

日本血栓止
血学会誌

22

368-373

2011

日本産婦人
科・新生児
血液学会会
誌

20（2） 75-82

日本人の血栓性素因、特宮田敏行、川崎富夫、坂田にプロテインS欠損症を
洋一、村田 満、小嶋哲人
中心に

細胞

2011

鈴木敦夫、小嶋哲人

エストロゲンによるProtein S 産生抑制

日本血栓止
血学会誌

22(5)

285-288

2011

小嶋哲人

血栓性素因の病因と病態
臨床血液

肝胆膵

52(10)

1454-14
60

2011

小嶋哲人

基礎の立場からみた新規
抗凝固薬

日本血栓止
血学会誌

22(4)

151-155

2011

小嶋哲人

経口トロンビン阻害薬では、なぜ頭蓋内出血の頻度が少ないのか —基礎の立場から—

日本心電学
会誌

31(3)

287-2912011

菅原宏丈、鈴木宗三、惣宇 東北地方に置ける血友病
利正善、小嶋哲人、一瀬白 インヒビター調査のまと
め
帝

山形医学

29(2)

37-44

2011

川崎富夫

法律時報

9･10 号 101-107

法律用語としての意思の成立と社会への影響

2011